Home › Astrocytoma › Michigan
Pag-aaral pangklinika para sa Astrocytoma sa Michigan
6 pag-aaral para sa Astrocytoma ang naghahanap ng mga kalahok sa mga site sa Michigan.
Mga Lungsod sa Michigan
Opisyal na teksto ng pag-aaral (English)
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- University of Michigan Rogel Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- at 2 pa
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07215910Targeted Pediatric High-Grade Glioma Therapy
- C.S. Mott Children's Hospital, Ann Arbor
Nagre-recruitObservasyonal na pag-aaral
12 Months – 39 Years · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05839379SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Henry Ford Hospital, Detroit
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT05303519Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- C.S. Mott Children's Hospital, Ann Arbor
Nagre-recruitPhase 2
12 Months – 39 Years · Lahat ng kasarian · Na-update May 29, 2026 · NCT05843253Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
- Henry Ford Health System, Detroit
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 16, 2025 · NCT05686798Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
- Henry Ford Hospital, Detroit
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 25, 2025 · NCT05879367Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.